This inventor holds 1 USPTO granted patent. Top assignees: Biofront Therapeutics (Beijing) Co., Ltd., Rk Pharmtech (Beijing) Ltd.. Active years: 2024.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2024
Title: Jin-Kui Yang: Innovator in Cathepsin L Inhibitors
Introduction
Jin-Kui Yang is a notable inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit Cathepsin L. His work has implications for treating various diseases related to this enzyme.
Latest Patents
Jin-Kui Yang holds a patent for Cathepsin L inhibitors. The patent details a plurality of compounds capable of inhibiting Cathepsin L (CatL). Additionally, it provides a composition that includes at least one of these compounds. The patent also outlines a method for treating or preventing one or more CatL-related diseases in a subject, which may involve administering the composition to the subject. He has 1 patent to his name.
Career Highlights
Throughout his career, Jin-Kui Yang has worked with various companies, including Biofront Therapeutics (Beijing) Co., Ltd. and Rk Pharmtech (Beijing) Ltd. His experience in these organizations has allowed him to advance his research and contribute to the field of pharmaceuticals.
Collaborations
Some of his notable coworkers include Lichao Fang and Yayi Wang. Their collaboration has likely enriched the research environment and fostered innovation in their projects.
Conclusion
Jin-Kui Yang is a prominent figure in the development of Cathepsin L inhibitors, with a focus on creating effective treatments for related diseases. His contributions to the field are significant and continue to impact biochemistry and pharmaceuticals.